In conversation with...
The Lancet Neurology
Editors of The Lancet Neurology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Episodes
Andrew Cole on the complexities underlying epilepsy in people with glioblastomaMay 18, 2023
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammationApril 13, 2023
Kerstin Hellwig on family planning considerations in MSMarch 15, 2023
Geraldine Dawson on advances in the prediction of autism during infancyFebruary 16, 2023
Ellisiv Mathiesen on tenecteplase for patients with wake-up strokeJanuary 19, 2023
Beau Ances on amyloid biomarkers in Alzheimer’sDecember 12, 2022
Axel Petzold on the diagnosis and classification of optic neuritisNovember 16, 2022
Maeike Zijlmans on using biomarkers to tailor epilepsy surgeryOctober 18, 2022
Jerome Siegel on sleep habitsSeptember 14, 2022
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophyAugust 10, 2022
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathyJuly 13, 2022
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapiesJune 15, 2022
Mark Hallett on functional neurological disorderMay 13, 2022
Eva Feldman on advances in understanding ALSApril 13, 2022
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer'sApril 06, 2022
John Collinge on a treatment for CJDMarch 16, 2022
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2February 22, 2022
Giuseppe Citerio on frailty and TBIJanuary 19, 2022
Alberto Costa on memantine in adolescents and young adults with Down syndromeDecember 20, 2021
Olivier Rascol on amantadine for patients with movement disordersNovember 17, 2021
Antonio Uccelli on stems cells for MSOctober 20, 2021
Priya Palta on blood pressure control and cognitive declineSeptember 15, 2021
Adam Boxer on tau biomarkersAugust 18, 2021
Irene Cortese on the difficulties of designing clinical trialsJuly 21, 2021
Doug Turnbull on mitochondrial diseases in adultsJune 16, 2021